Cargando…
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
BACKGROUND: The severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is extremely variable, ranging from asymptomatic patients to those who develop severe acute respiratory distress syndrome (ARDS). As for now, there are still no really effective therapies for coronavir...
Autores principales: | Menzella, Francesco, Fontana, Matteo, Salvarani, Carlo, Massari, Marco, Ruggiero, Patrizia, Scelfo, Chiara, Barbieri, Chiara, Castagnetti, Claudia, Catellani, Chiara, Gibellini, Giorgia, Falco, Francesco, Ghidoni, Giulia, Livrieri, Francesco, Montanari, Gloria, Casalini, Eleonora, Piro, Roberto, Mancuso, Pamela, Ghidorsi, Luca, Facciolongo, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523258/ https://www.ncbi.nlm.nih.gov/pubmed/32993751 http://dx.doi.org/10.1186/s13054-020-03306-6 |
Ejemplares similares
-
A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia – Case Reports
por: Scelfo, Chiara, et al.
Publicado: (2020) -
Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab
por: Menzella, Francesco, et al.
Publicado: (2021) -
Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
por: Menzella, Francesco, et al.
Publicado: (2020) -
Real world effectiveness of benralizumab on respiratory function and asthma control
por: Menzella, Francesco, et al.
Publicado: (2021) -
Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life
por: Menzella, Francesco, et al.
Publicado: (2022)